Transcript Highlights:

• opioids opioids just<03:50:51.000> there.
• <04:32:30.760> Uh uh to both non-opioids and opioids.
• Uh uh to both non-opioids and opioids.
• opioids are. opioids are.
• opioid addiction. opioid addiction.

Keywords: 981, all

Summary: The House convened with a quorum, approved the journal, and heard several announcements and recognitions. Members marked World Ovarian Cancer Day, promoted Cinco de Mayo and a related potluck, welcomed DeMolay International guests, and recognized correctional officers and employees during Corrections Officers and Employees Week. Several committees also announced upcoming meetings and bill hearings, including Health and Human Services, Judiciary, Transportation, Housing, and Local Government, Capital Development, and Appropriations. Committee reports were read, including favorable recommendations on several bills and a postponement indefinitely of House Joint Resolution 1029. The Majority Leader then moved a slate of bills to special orders, and the House agreed without objection. The chamber then proceeded to floor consideration of Senate Bill 134, concerning payment card network fees. Senate Bill 134 drew debate over whether merchants should continue paying swipe fees on the tax portion of credit card transactions. Supporters said the bill would provide meaningful relief to small businesses and restaurants, with estimated savings of $8,000 to $10,000 per business and about $217 million statewide. Opponents argued the bill shifted costs to banks and could have unintended consequences, suggesting the state should instead directly pay or reimburse the fees. After debate, the House passed Senate Bill 134 by voice vote.

Transcript Highlights:

• by the full opioid commission.
• A lot of people are doing really good work as you... doing really good work as you recall the opioid
• Pardon and Parole received $120,000 for a passenger van to expand opioid treatment programs throughout
• Alabama Sheriff Association received $2.6 million for opioid prevention programs, including in inmate
• opioid treatment costs and the management of opioid impact zones in our jails.

Bills: HB186, HB185, HB184, HB183, HB181, HB312, HB405, HB182, HB460

Keywords: Alabama budget, general fund appropriations, fiscal year 2026, state budget, appropriations act, HB186, executive branch funding, legislative branch funding, judicial branch funding, debt service, capital outlay, corrections, Medicaid, public health, mental health, transportation, education, law enforcement, tourism, veterans affairs

Transcript Highlights:

• Laboratory studies like opioids.
• <01:52:06.320> or<01:52:06.639> opioid applied to every other opioid or opioid applied
• <01:57:36.239> receptor containing opioid receptor containing opioid receptor opioid<01:57
• We've heard that it targets the opioid receptors much like an opioid would.
• products there resemble more opioids. products there resemble more opioids.

Keywords: 1191, senate, all

Transcript Highlights:

• Does cannabis alter opioid-induced respiratory depression? of opioid withdrawal?
• <01:28:18.880> rewarding cannabis may alter opioid rewarding cannabis may alter opioid rewarding
• > induced Does cannabis alter opioid induced Does cannabis alter opioid induced respiratory<01
• <01:29:06.800> use to take opioids in those with opioid use to take opioids in those with
• opioid use disorder.

Keywords: 958, all

Summary: The committee met and approved the minutes from its August 27 meeting. It then received a presentation from Katherine Castanza of the National Conference of State Legislators on the Medicaid provisions in the 2025 budget reconciliation bill, referred to as HR1. She explained that the bill is estimated by CBO to save the federal government $911 billion over 10 years, with more than 20 Medicaid-specific provisions, most of the savings concentrated in five policies and largely backloaded into 2030-2034. She emphasized that the bill’s effects will vary by state, but that expansion states and hospitals are expected to be most affected, in part because of changes to eligibility, provider taxes, and state-directed payments. Castanza highlighted several new funding and flexibility provisions, including a $50 billion Rural Health Transformation Fund for 2026-2030 and a new home- and community-based services waiver option effective July 1, 2028, with $100 million in grants in fiscal year 2027. She also outlined major eligibility changes for Medicaid expansion adults: work or community engagement requirements effective January 1, 2027; twice-yearly redeterminations for the expansion population effective the same date; and new cost sharing for certain expansion adults effective October 1, 2028. She noted that Kentucky, as an expansion state, would be subject to these changes and that state agencies would face significant implementation demands, especially because federal guidance and timelines are tight. A substantial portion of the presentation focused on financing changes. Castanza described new limits on provider taxes, including a 0% safe harbor for new taxes and a phased reduction for existing taxes in expansion states beginning in 2028, while nursing facilities and intermediate care facilities are exempt from the reduction if already taxed. She also explained that state-directed payments will be capped and phased down over time, with existing arrangements grandfathered only briefly; she said Kentucky has 11 approved state-directed payments and could see significant fiscal effects. She added that the bill also bars Medicaid payments to Planned Parenthood or similarly situated providers for one year, changes immigrant eligibility rules effective October 1, 2026, lowers the federal match for certain emergency services, and expands the scope of the federal erroneous payment recoupment provision effective October 1, 2029. Throughout, she stressed that federal savings may translate into state cost shifts and that implementation timing will be critical.

Transcript Highlights:

• An opioid prevention center is one designed for people with an opioid addiction but not excluding other
• Trained professionals equipped to battle the disease of opioid addiction.
• An opioid is a highly addictive drug, which is the problem.
• The opioid misuse academic has also hurt our state's economy, driving down labor participants, The opioid
• Like many others here, I have also lost loved ones to the opioid epidemic.

Keywords: 995, all

Summary: The Joint Committee on Mental Health, Substance Use, and Recovery held a public hearing on several harm reduction bills, including measures to decriminalize simple possession and paraphernalia, authorize overdose prevention centers, and expand access to naloxone for first responders. Chair Mindy Domb and Senator John Velis opened by describing harm reduction as an evidence-based public health strategy and noting Massachusetts’ recent decline in fatal overdoses. They emphasized that testimony would help shape whether and how the bills advance, and explained the hearing process, including time limits and written testimony. Testimony was sharply divided. Supporters, including Rep. Kate Donaghue, Sen. Cindy Friedman, Rep. Marjorie Decker, Rep. Manny Cruz, public health professionals, recovery advocates, and people with lived experience, argued that harm reduction saves lives, reduces stigma, and can connect people to treatment. They supported overdose prevention centers and decriminalization as tools to keep people alive long enough to enter recovery, and several speakers described personal losses to overdose or family experiences with addiction. Some supporters also framed the bills as racial justice measures, arguing that criminal penalties for possession have disproportionately harmed Black and brown communities. Opponents, including Sen. Nick Collins and several South End residents, argued that overdose prevention centers and decriminalization would worsen public drug use, crime, and neighborhood disorder, especially around Mass and Cass. They said current approaches such as Section 35, diversion, and police leverage into treatment are more effective, and they urged more treatment beds and recovery facilities instead of harm reduction sites. Committee members questioned witnesses about research, local siting, crime data, and the relationship between harm reduction and treatment, and several members said neighborhood impacts must be considered alongside overdose prevention. The committee did not take a vote during the hearing; it continued receiving testimony and announced a later break before resuming on H. 2196 and S. 1393.

Transcript Highlights:

• The use of opioids in this country was the most concerning.
• way that opioid substances do to the new opioid receptors in the brain.
• for their opioid use disorder or intractable pain with disastrous results.
• And at that point, they highly recommended that Big Pharma look at 7-OH as a potential opioid-safe opioid
• Those opioid deaths begin to fall early in '24.

Keywords: 995, all

Summary: The hearing covered a wide range of Judiciary Committee bills, with much of the testimony focused on criminal justice, public safety, and civil asset forfeiture reform. Several lawmakers and advocates supported bills to increase penalties or create new offenses related to assaults on sports officials, assaults on transit workers, reckless discharge of firearms, fires and explosives, pill press machines, and drug-induced homicide. Testifiers described rising harassment and violence against youth sports officials and transit workers, as well as the fentanyl overdose crisis and the need for stronger tools to prosecute dealers whose conduct leads to death. Supporters of the sports-official and transit-worker bills emphasized declining referee availability and repeated assaults on commuter rail and MBTA workers. District attorneys also backed bills on reckless firearm discharge and fires/explosives, saying current law does not adequately address dangerous conduct that endangers bystanders. The committee also heard testimony on several proposals related to youth diversion and prison mitigation. Supporters of the youth court justice fund bill said youth courts are peer-led diversion programs with strong compliance and low recidivism, and argued for a stable funding source rather than annual earmarks. A representative from Bridgewater supported a prison mitigation fund for municipalities that host state prisons, saying the costs of public safety and emergency services are not fully covered. On gun policy, testimony split between supporters of a bill to ban in-state manufacture of assault-style rifles for civilian sale and opponents or skeptics of other firearm-related measures, including a bill on collateralizing firearms and a bill to increase penalties for drug trafficking combined with illegal firearm offenses. A major portion of the hearing was devoted to civil asset forfeiture reform. Advocates from the ACLU, CPCS, the Boston Bar Association, the Institute for Justice, and others supported bills to increase the burden of proof, improve transparency and reporting, require counsel, and limit or eliminate the current practice of directing forfeiture proceeds to law enforcement. They argued the current system creates perverse incentives, lacks adequate due process, and is insufficiently transparent. District Attorney Paul Tucker defended current forfeiture practices, saying his office has reporting and oversight, uses the funds for investigations and community programs, and warned that reducing forfeiture revenue would hinder crime fighting. No votes or final committee actions were taken during the hearing; the chairs repeatedly thanked witnesses and indicated the bills would remain under consideration.

Transcript Highlights:

• It's been key in reducing some of the terrible outcomes of our opioid epidemic.
• and most effective opioid treatment for opioid use disorder, which decreases deaths from opioid use disorder
• Opioid Policy Research Collaborative at Brandeis.
• Someone who has been personally affected by an opioid overdose. I personally am no exception.
• I have lost count of the number of lives I've seen taken by opioids.

Keywords: 995, all

Summary: The Joint Committee on Public Health held a hearing focused on children’s health, disease prevention, screening, treatment, and pharmacy-related bills. The chair explained that the session was for public testimony only, with no votes or decisions taken that day, and outlined the three-minute limit for individual testimony. The committee then heard testimony on a range of bills, including H. 2413 on adding electromagnetic sensitivity to the state’s MAVEN registry, S. 1508 and H. 2433 on creating an amputation prevention task force, H. 2535 and S. 1551 on establishing a naloxone purchase trust fund, S. 1635 on authorizing pharmacists to provide opioid use disorder treatment, H. 2385 on creating a special commission on avian influenza, and S. 1497 on patient safety and non-FDA-approved compounded drugs. Testimony on H. 2413 came largely from advocates and individuals who described electromagnetic sensitivity as a real health condition and argued that adding it to the registry would improve data collection, provider education, and public awareness. Testimony on the amputation prevention task force bills came from the American Diabetes Association and podiatry groups, who said diabetes-related amputations are often preventable, disproportionately affect people of color, and could be reduced through earlier screening, better care coordination, and improved insurance coverage for preventive foot care. On the naloxone trust fund bills, a representative, emergency physician, and nurse testified that hospitals often cannot reliably send overdose patients home with naloxone because of billing and reimbursement barriers, and that a bulk-purchase fund would expand access at no added cost to payers or providers. The committee also heard strong support for S. 1635 from pharmacists and public health researchers, who said community pharmacists could safely initiate and maintain buprenorphine treatment and help close gaps in opioid use disorder care. On H. 2385, a local board of health chair supported a special commission on avian influenza, citing gaps in emergency preparedness and the need for clearer coordination across agencies. On S. 1497, a pharmacy representative opposed restrictions on compounded drugs from outsourcing facilities, warning that changes could reduce access to life-saving medications and harm patient safety. No votes or formal actions were taken during the hearing.

Transcript Highlights:

• So we will now go to our the opioid settlement update, the Attorney General overview Julia Meade, and
• And Julie Meade: I'm here to give you an overview of the opioid settlements.
• But we've never tried this injectable opioid treatment program.
• Back then, the opioid settlement fund hadn't been created in the legislature.
• Is injected with an opioid, hydromorphone. I'm wrapping it up.

Transcript Highlights:

• opioid use disorder, or OUD. opioid use disorder, or OUD.
• oral opioid analgesic therapy.
• oral opioid analgesic therapy.
• oral opioid analgesic therapy.
• oral opioid analgesic therapy.

Bills: HF4493, HF3133, HF4595, HF4143, HF4142, HF3756, HF4289, HF1724, HF2291, HF4568, HF4547

Keywords: opioid use disorder, OUD, medication-assisted treatment, MAT, pharmacist prescribing, pharmacy practice, controlled substances, Schedule III, Schedule IV, Schedule V, DEA registration, Board of Pharmacy, substance use disorder, addiction treatment, buprenorphine, naltrexone, harm reduction, prescription authority, pharmacist intern, Minnesota pharmacy law

Transcript Highlights:

• Families are still<00:19:20.160> wrestling<00:19:20.480> with<00:19:20.720> opioid
• c><00:19:21.200> addiction still wrestling with opioid addiction still wrestling with opioid addiction
• <00:19:45.840> use<00:19:46.080> disorder,<00:19:47.200> coco for opioid use
• in the middle of an ongoing opioid in the middle of an ongoing opioid crisis.<00:25:44.480> It
• that we can have research on opioid that we can have research on opioid addiction<01:10:44.880><

Keywords: MS House Floor - 21 January, 2026; 2:00 PM, 925, all

Summary: The House opened with prayer, the Pledge of Allegiance, a quorum call, and several guest introductions, including a pastor, a doctor of the day, medical students and physicians for MSMA White Coat Day, and visitors in the galleries. The chamber then moved to the calendar and took up House Bill 314, the Ibogaine Treatment Drug Development Grant Program Act. The sponsor described ibogaine as a potential treatment for opioid use disorder, PTSD, traumatic brain injury, depression, and related conditions, emphasizing that the bill would not legalize the drug but would authorize the State Department of Health to fund a consortium for FDA-regulated clinical trials with private matching funds, a university and hospital partner, and a requirement that at least 20% of commercialization revenue go to the state. Members asked about VA involvement, whether the trials would serve veterans or civilians, how the drug would be administered and monitored, why a statute was needed, and the source of the proposed state funding. The bill passed by a vote of 110 yeas and 1 nay. The House then considered House Bill 534, as a committee substitute, creating the Mississippi Health Exchange, a statewide health information exchange for real-time sharing of admission, discharge, transfer, and related patient information among hospitals, clinics, payers, and public health officials. The sponsor said the system would improve continuity of care, help with bed availability and mental health placements, and support public health analysis while protecting privacy through HIPAA compliance, an opt-out process, and limits on access to identified data. The bill would require hospitals, community mental health centers, and state hospitals to participate as a condition of licensure, designate a single nonprofit operator selected by the Department of Health, and create a fund for implementation and cybersecurity costs. Members questioned the bill about privacy protections, the opt-out process, whether data could be sold or shared improperly, costs to hospitals, whether hospitals and the hospital association supported the measure, and how the exchange would work in transfer scenarios. The sponsor said the bill would make unauthorized sharing illegal, that most hospitals already participate in some form of HIE, and that the exchange would not cost the state anything immediately because there was no appropriation attached. The discussion also noted possible help from rural transformation funding. The transcript ends during continued questioning of House Bill 534, before final passage or other action is shown.

Transcript Highlights:

• pharmacologically like opioids. pharmacologically like opioids.
• >> Someone who's already taking an opioid >> Someone who's already taking an opioid
• opioids, you should not take this? opioids, you should not take this?
• >> an opioid. >> an opioid.
• Well, opioid.

Keywords: 1189, house, all

Transcript Highlights:

• withdrawal symptoms and blocking the effects of other opioids.
• Opioid, you know, there's just so many. Opioid, you know, there's just so many.
• I talked a little bit ago about kratom as a wimpy opioid.
• I think it's fair to say that 7-OH is a potent opioid.
• For opioid use disorders, the rates have come up thanks to Dr.

Summary: The meeting focused on Missouri’s substance use prevention and treatment system, with repeated emphasis on recovery support services, peer support, recovery housing, transportation, and harm reduction. Dan Haniken of Into Action described his own recovery from addiction and incarceration and argued that treatment alone is not enough; he urged greater investment in recovery housing, peer support, employment, and community-based supports that help people stay sober and avoid relapse. Members asked about funding sources, program capacity, referrals, treatment court, transportation, and how Into Action supports people on medication-assisted treatment (MAT). Haniken said the organization is funded through a mix of federal, state, county, city, foundation, and private donations, and that housing and transportation remain major barriers, especially because support is often funded for too short a period compared with the longer time people need to stabilize. Matt Cushman of the Raytown Fire Protection District gave a strong endorsement of harm reduction, including naloxone distribution, syringe service programs, and broader decriminalization of harm reduction tools. He argued that stigma is a major barrier to care and that Missouri should expand access to clean needles, test strips, and other services, while also improving access to MAT in jails and communities. Committee members questioned the evidence base, the role of faith-based providers, and whether safe consumption sites should be pursued; Cushman said syringe exchange decriminalization should be the immediate priority, while safe consumption sites are a longer-term issue. He also described community paramedicine and mobile integrated health as valuable but funding-dependent, and said naloxone distribution is improving but still uneven, especially in rural and minority communities. Representatives from Central Ozarks Medical Center and Four Rivers Community Health Center highlighted the importance of peer support specialists, community health workers, care coordinators, and wraparound services in rural health centers. COMC’s Morgan McClure and Monet Lehman described a jail reentry program in Pulaski County, with Lehman sharing her trauma and recovery story and explaining how she helps incarcerated people prepare for release with housing, employment, benefits, transportation, and treatment connections. Four Rivers’ Devon Polarys and Cassandra Trout said their CEO would change Missouri policy to allow FQHCs to receive reimbursement for peer support and community health worker services similar to CCBHCs, arguing that these roles are essential for addressing barriers like transportation, housing, food insecurity, and insurance. Members discussed confusion over reimbursement rules, the differences between FQHCs and CCBHCs, and the need for better funding and clearer policy for peer and community health worker services. No votes were taken; the discussion ended with a suggestion to bring in a subject matter expert on community health workers for a future session.

Transcript Highlights:

• Now, let's go to Tab 2, Senators, and that is Senate Bill 714 on non-opioid advanced directives, and
• We have 10 states that have already implemented the voluntary non-opioid advance directive laws.
• The voluntary non-opioid directive does not alter any other advance health care directive.
• I just like the idea, but how will patients know that this non-opioid advance directive is available?
• You either had, you know somebody who's had an issue with opioids who did not have the opportunity to

Summary: The Committee on Health Policy met with a quorum and considered three bills. Senate Bill 526 on nursing education programs, sponsored by Senator Harrell, would tighten oversight of nursing schools by requiring admission criteria, exit exams, remediation plans, annual reporting, on-site inspections, and stronger action against programs with poor NCLEX results or adverse actions in other jurisdictions. After testimony from the sponsor and several committee questions, a late-filed amendment restored a two-year probation period instead of one year, and the bill was reported favorably. Senate Bill 714, also by Senator Harrell, would create a voluntary non-opioid advance directive allowing patients to document a wish not to receive opioids, including when incapacitated, with the form developed by the Department of Health and potentially included in electronic medical records. The sponsor said it would not prevent treatment discussions and would provide liability protection for providers who lack actual knowledge of the directive in emergencies. The bill drew no opposition in the meeting and was reported favorably. Senate Bill 170, sponsored by Senator Burton, would add nursing home quality and transparency measures, including consumer satisfaction surveys, patient safety culture surveys, electronic health record requirements, reporting to the Florida Health Information Exchange, a $10,000 fine for failure to submit required financial data, and reporting on Medicaid quality payments. An amendment clarified the fine’s application to both facilities and home offices. Testimony from AARP and the Florida Health Care Association supported the bill, and it was reported favorably after discussion about implementation and costs.

Transcript Highlights:

• opioid stimulants and benzodiazepines. opioid stimulants and benzodiazepines.
• <01:20:05.480> prescription, for an opioid prescription, for an opioid prescription, one<01
• So we would expect amount of opioids.
• , palliative care instead of opioids, palliative care instead of opioids, we'll<01:22:55.600>
• > prescription<01:36:19.000> rates if you see opioid prescription rates if you see opioid

Keywords: 1189, house, all

Summary: The committee met on May 29 and approved the draft minutes. DHHS Commissioner Weaver then opened the department update by asking Medicaid Director Henry Litman to brief members on federal and state Medicaid changes, and later turned to DHHS Chief Operating Officer David Weathers for an update on data governance. Members also asked that acronyms be spelled out in future materials and requested a follow-up on the federal Medicaid rule once it is published. Litman reviewed several federal Medicaid provisions tied to HR 1/"OBBA" and related state implementation issues. He said the first major change would be restrictions on certain non-citizens’ Medicaid coverage, affecting about 400 people in New Hampshire, with notices likely 30 to 60 days before the effective date. He also discussed new work requirements/community engagement rules, saying New Hampshire is on track to implement them and will likely need a state plan amendment rather than an 1115 waiver. Other changes included shorter retroactive coverage periods, a new state option for certain community-based services with an estimated $740,000 in implementation support, a freeze and phased-down reduction in the Medicaid enhancement tax beginning in state fiscal year 2029, and limits on directed payments to hospitals after a grandfathering period. He also noted that Medicaid enrollment has fallen from pandemic-era levels, with about 167,000 people covered as of May 1, and that the department is working with CMS on child premiums and other cost-sharing changes approved in HB 2. Committee members asked how the department could plan for the 2029 changes given the number of elections before then, and Litman said federal rules may be adjusted over time as states and stakeholders raise concerns. He emphasized planning for the worst while hoping for the best, and said rural health care transformation funding would help the state prepare. In the second presentation, Weathers explained that data governance is now embedded in DHHS operations to control access, manage reporting, and respond to risk. He defined it as managing what data is collected, how it is used, who can access it, and what laws apply, and said DHHS has moved from governance as a committee to governance as an operational process. He described privacy impact assessments for new systems going into production, monthly privacy and security training, and ongoing review of access controls and data-sharing rules.

Transcript Highlights:

• HB 2444 does not authorize opioid treatment. Opioids are explicitly prohibited.
• each opioid that was dispensed.
• Our role in providing education for opioid overdose predates our most current opioid or fentanyl epidemic
• Our role in providing education for opioid overdose predates our most current opioid or fentanyl epidemic
• for opioid overdose for victims, and are the only life-saving therapies available for opioid overdose

Keywords: 1182, all

Summary: The committee heard House Bill 2433, which would require insurers offering Medicare supplement policies to people 65 and older to also offer them to Medicare beneficiaries under 65 with ALS or end-stage renal disease, with enrollment periods and premium protections tied to 65-year-old rates. Supporters, including dialysis and ALS advocates, said the bill would help a small population facing high out-of-pocket costs and could improve access to transplants and care; opponents argued it would shift costs onto older seniors and raise Medigap premiums. The committee recommended the bill do pass on a 12-0 vote. The committee also heard House Bill 2593, appropriating $1.5 million to the University of Arizona for the Arizona Perinatal Psychiatry Access Line. The sponsor and physicians testified that the line helps obstetric and pediatric providers quickly consult on perinatal depression, postpartum psychosis, suicidality, and other mental health crises, improving outcomes for mothers, children, and families and reducing costly emergency and crisis care. The bill received a do pass recommendation on a 10-1 vote. House Concurrent Resolution 2013, proclaiming June 2026 as Celebrate Life Month, drew emotional testimony from a young woman with spina bifida and another speaker supporting the sanctity of life. Some members objected that the state should focus on practical supports such as paid leave, child care, and health care access, while others supported the resolution as a statement of human dignity. The resolution passed the committee 7-5. The committee then approved House Bill 4010, creating a Board of Genetic Counselors and licensure standards, after testimony from genetic counselors and a patient advocate about the need for qualified counseling and better access; it passed 11-1. Later, the committee approved House Bill 2196, which would require pharmacy benefit managers to reimburse non-affiliated pharmacies at least their acquisition cost and pay a dispensing fee, and establish an appeals process. Independent pharmacists and their coalition said PBM practices are driving closures and unfairly favor affiliated pharmacies, while PBM and employer representatives warned of major cost increases and said the bill would interfere with private contracts; the bill passed 11-1. The committee also adopted a strike-everything amendment to House Bill 2182 requiring insurers and health plans to report claims denial and prior authorization data to DIFI, and then gave the amended bill a 12-0 do pass recommendation. Finally, the committee approved House Bill 2189, directing the Board of Nursing to update rules for licensed health aides and collect annual data, with the sponsor and board staff saying it would help implement routine ventilator care in the home; it passed 12-0. The committee then began hearing House Bill 2404, a strike-everything amendment on inter-facility transports for behavioral health patients, but the transcript cuts off before action on that bill.

Transcript Highlights:

• We also combat opioid use in a number of ways in this bill through education, antagonists, and opioid
• We also combat opioid use in a number of ways in this bill through education, antagonists, and opioid
• We also combat opioid use in a number of ways in this bill through education, antagonists, and opioid
• use in a number of ways in this opioid use in a number of ways in this bill<00:10:42.800> through
• directives for non-usage in uh opioid directives for non-usage in uh medical<00:10:48.320> health

Bills: HF2436, HF2435

Keywords: child welfare, economic assistance, child care, grant program, video security cameras, healthcare, dementia services, public health funding, opioid prevention, women's health, community health boards, mental health, 1183, house

Transcript Highlights:

• Opioid use is also being reduced thanks to ATRIP and our statewide opioid stewardship program, which
• to atrip and our Statewide opioid to atrip and our Statewide opioid stewardship<00:31:05.480>
• 2019 measures from the opioid 2019 measures from the opioid stewardship<00:31:12.200> program
• in patients getting multiple opioid in patients getting multiple opioid prescriptions prescriptions
• with multiple opioid with multiple opioid prescriptions<00:31:34.639> and<00:31:34.799>

Keywords: 00:00 Call to Order/Roll Call 00:16 Consideration of Referred Administrative Regulations 25:49 Discussion of Hospital Rate Improvement Plan 58:50 Adjournment, 958, all

Summary: The committee began by reviewing a large slate of administrative regulations and explaining that it does not approve regulations but can find them deficient and send them back for further work. Members then asked questions on several items, including EMS reciprocity, dental hygienist licensure, and interpreter licensure. The EMS board explained that reciprocity would extend to applicants from any state, not just contiguous states, because the underlying statute had been amended. On the dental regulation, staff said the changes mainly clarified licensure requirements, reinstatement fees, and that dental hygienists administering local anesthetic must do so under direct dentist supervision. The most extended discussion involved the Board of Interpreters for the Deaf and Hard of Hearing. The board chair said the main concern was that the EIPA is an educational specialty assessment, not a nationally recognized certification, yet the regulation would allow it to support full licensure. Members discussed whether that could let educational interpreters work outside their intended scope and whether a separate educational license or statutory change would be more appropriate. The board said it did not think the regulation could be fixed further at this point and suggested a statute could create a narrower educational interpreter license. After discussion, the committee voted to defer both related interpreter regulations, 201 KAR 39:030 and the companion regulation, for further work. The committee then took up two community mental health regulations, 907 KAR 1:044 and 907 KAR 5:005, which had been found deficient in Administrative Regulations. Department for Medicaid Services staff said the rules would expand and rename the mental health associate role as a behavioral health associate, making the role available in many more facilities, but would also require additional coursework or progress toward licensure. Some members and providers raised access-to-care concerns, especially for rural areas and unlicensed staff already working in the field. Staff said the proposal had been revised through work with CMHCs and licensing boards, but the committee ultimately voted to defer both regulations as well. After finishing the regulation review, the committee heard a presentation from the Kentucky Hospital Association on the ATRIP hospital rate improvement program. Hospital representatives said ATRIP is a Medicaid state-directed payment program funded through a provider tax and federal matching dollars, allowing hospitals to receive payments tied to quality measures. They reported improvements including lower Medicaid readmissions, high sepsis screening rates, reduced infections and opioid prescribing, expanded postpartum depression and suicide screening, and training for more than 1,000 people. They said the program has helped hospitals invest in staffing and quality improvement and warned that without it, many hospitals would face severe financial strain.

Transcript Highlights:

• overdoses and opioid-related deaths.
• 30 days on that opioid.
• overdoses and opioid-related deaths.
• 30 days on that opioid.
• opioids opioids with<00:04:52.639> cost<00:04:53.520> and<00:04:53.840> insurance

Keywords: Medicaid - Room 216, 4 February, 2026; 2:00 PM, 925, all

Summary: The committee heard presentations on several Medicaid-related topics. First, a pharmacy representative discussed nonopioid pain medications as a way to reduce opioid dependence and overdose risk, emphasizing that options such as acetaminophen, NSAIDs, and topical diclofenac can be useful for pain management. She cautioned that nonopioids can still have risks and said any policy should avoid requiring patients to step through opioids before accessing safer alternatives, while still allowing reasonable step therapy among nonopioid options. The presenter said the goal is to keep patients from being pushed toward opioids by cost or insurance design. The committee also heard emotional testimony from parents of a child with Prader-Willi syndrome, who described the condition as a rare genetic disorder that causes severe, lifelong hyperphagia and requires rigid supervision and ongoing treatment. They argued that alternative funding programs can disrupt access to medically necessary drugs such as human growth hormone, forcing families into costly and uncertain coverage gaps. They asked lawmakers to ensure insurance coverage remains stable for rare disease patients and thanked Senator Blackwell for prior support of rare disease legislation. Next, a Livanova representative urged the committee to support higher Medicaid reimbursement for vagus nerve stimulator surgery for drug-resistant epilepsy. He said inadequate hospital reimbursement has reduced access in Mississippi, causing patients to travel long distances or go without treatment, and argued that better reimbursement would improve outcomes and save money over time. He cited studies showing seizure reductions, lower ER use, and a projected $2.8 million in five-year savings for Medicaid based on 40 patients, and asked that hospitals be reimbursed at 100% of Medicare rates for the procedure codes. Finally, a Medicaid official gave a broad overview of hospital payment structure, including fee-for-service, managed care, MHAP, DSH, UPL, provider taxes, and related funding mechanisms. She explained that hospital payments are interrelated and have shifted over time, with major changes tied to managed care, MHAP/UPL increases, and provider taxes. At the end of the discussion, the committee was running short on time and asked her to skip ahead to the provider tax component; no votes or formal actions were taken in the portion provided.

Transcript Highlights:

• Non opioid advanced directives and you are recognized. Thank you.
• We have 10 states have already implemented a voluntary non opioids advanced directive laws.
• Advanced directive and the voluntary non opioids directive does not prohibit the conversation between
• a patient and healthcare professional regarding their treatment options to include opioids.
• But how will patients know that this non-opioid advanced directive is available?

Keywords: 999, senate, all

Transcript Highlights:

• authorizing pharmacists to initiate, prescribe, administer, and dispense certain drugs for the treatment of opioid
• And also, I commend him for all of his work all these years on the opioid epidemic response advisory
• "I commend him for all of his work all these years on the opioid epidemic response advisory council.
• We're in at least our fourth wave of the opioid epidemic, and the reasons are different, but we need
• We're in at least our fourth wave of the opioid epidemic, and the reasons are different, but we need

Keywords: 1183, house

Summary: House File 4493 would authorize pharmacists to initiate, prescribe, administer, and dispense certain drugs for opioid use disorder, especially buprenorphine/Suboxone. Representative Baker said the bill is intended to save lives by giving people immediate access to treatment at the moment they seek help, rather than making them wait for a doctor’s appointment or navigate more cumbersome methadone access. He emphasized that pharmacists are widely accessible, including in greater Minnesota, and that optional training would support safe prescribing. Representative Bierman spoke in strong support, calling the measure a life-or-death step forward for people with substance use disorder and noting that many people do not receive treatment when they need it. He said he initially had concerns but Baker listened to his suggested changes and worked with him and bill drafters, which helped address those concerns. Bierman also referenced the ongoing fentanyl crisis and encouraged members to learn more from displays honoring overdose victims. Baker closed by sharing personal remarks about losing his son to addiction and describing how limited treatment options were at that time. He said the new federal change allowing pharmacist training makes the bill timely and urged members to support it. After discussion, the House took a roll call vote and passed the bill 134-0, with the title agreed to.